September 10, 2025

Advancesin Immunotherapy for Head and Neck Squamous Cell Carcinoma.

View Full Paper

Ask AI

Bookmark

Immunotherapy shows promising efficacy in treating head and neck squamous cell carcinoma, improving patient outcomes significantly.
Recent advances indicate that immunotherapy may shift from palliative care to curative treatment for locally advanced cases.
The review discusses current systemic and local therapy modalities, including chemotherapy, targeted therapy, and radiotherapy.
With its high specificity and low toxicity, immunotherapy may enhance quality of life for patients with head and neck tumors.

Discussion

No takes yet. Share an insight, caveat, or question.

This review summarizes developments in immunotherapy for head and neck squamous cell carcinoma, highlighting its growing role in treatment options.

Cao et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This review summarizes developments in immunotherapy for head and neck squamous cell carcinoma, highlighting its growing role in treatment options.